InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（17 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
17
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Krognes Steve E., 首席财务官. Insider active across 2 companies, notably Denali Therapeutics Inc.. In total, 60 reports have been published. Breakdown: 0 buy · 17 sells. Total volume traded: €3.9m. Activity tracked since 19 August 2021. The latest transaction was filed on 3 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Krognes Steve E.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报60 总计
6,408 股0Common StockSEC:0001666236-26-000015:0
154 股0Common StockSEC:0001666236-26-000011:0
155 股0Common StockSEC:0001666236-26-000009:0
154 股0Common StockSEC:0001666236-26-000006:0
154 股0Common StockSEC:0001666236-26-000004:0
154 股0Common StockSEC:0001666236-26-000002:0
155 股0Common StockSEC:0001666236-25-000013:0
154 股0Common StockSEC:0001666236-25-000011:0
154 股0Common StockSEC:0001666236-25-000009:0
155 股0Common StockSEC:0001666236-25-000007:0
154 股0Common StockSEC:0001576280-25-000248:0
154 股0Common StockSEC:0001576280-25-000211:0
6,674 股0Common StockSEC:0001576280-25-000175:0
6,037 股0Common StockSEC:0001714899-25-000139:0
154 股0Common StockSEC:0001576280-25-000155:0
155 股0Common StockSEC:0001576280-25-000138:0
154 股0Common StockSEC:0001576280-25-000108:0
154 股0Common StockSEC:0001576280-25-000048:0
154 股0Common StockSEC:0001576280-25-000032:0
3,339 股@ US$20.811.6% 占其流量Common StockSEC:0001714899-25-000048:0
30,000 股@ US$20.2513.9% 占其流量Common StockSEC:0001714899-25-000002:0
155 股0Common StockSEC:0001576280-25-000002:0
154 股0Common StockSEC:0001576280-24-000289:0
154 股0Common StockSEC:0001576280-24-000253:0
30,000 股@ US$29.0318.7% 占其流量Common StockSEC:0001714899-24-000200:0
60 条申报中的 25 条
About Krognes Steve E.
Krognes Steve E. is Director Financier and has 60 filings in total. Among the recent filings available, they cover the period from 2021-08-23 to 2026-06-05, with 0 in buys and 3929871 in sells, mainly as Levée d'options, at Denali Therapeutics Inc. and Guardant Health, Inc.
